The global clinical pipeline contains over 22,000 active compounds. Yet 90% of candidates fail. AI, regulatory reform, and new modalities are reshaping how drugs go from target discovery to commercial launch.
Scaled Cognition raised a 100M Series A led by Khosla Ventures to build APT, a model that eliminates AI hallucinations through architectural design, not safety wrappers.
SpaceX, Google, and Nvidia are racing to put AI data centers in orbit. The economics are unproven, but terrestrial power constraints are narrowing the gap faster than expected.
Ex-Waymo engineers raised $270M to retrofit excavators and bulldozers with autonomy — turning construction equipment into machines that work without operators.
The WEF's 3C framework — combination, convergence, compounding — explains why the winners in tech are no longer the most advanced, but the most ready to integrate.
NewLimit raised $435M at $3.1B valuation for the first human trial of epigenetic reprogramming. A chronicle of the company's journey from seed to clinic.
Deloitte data shows Gen Z spends 54% more time on social platforms than average — and 44% of fans discover content there first.
Suno closed $400M Series D at $5.4B valuation — more than double its November 2025 price. The AI music platform hit 2M paid subscribers, projects $300M ARR, and faces $9B in potential copyright damages from UMG and Sony. Warner Music chose to license instead.